Acetylcholinesterase inhibitive activity-guided isolation of two new alkaloids from seeds of Peganum nigellastrum Bunge by an in vitro TLC- bioautographic assay

Archives of Pharmacal Research

Volumn 32, Issue 9, 2009, Pages 1245-1251

  Wang, Chang Hong ^a   Zheng, Xi Yuan ^b   Zhang, Zi Jia ^b   Chou, Gui Xin ^b   Wu, Tao ^b   Cheng, Xue Mei ^b   Wang, Zheng Tao ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b NONE

Author keywords

Acetylcholinesterase; Alkaloid; Alzheimer's disease; Nigellastrine I; Nigellastrine II; Peganum nigellastrum Bunge; TLC bioautographic assay

Indexed keywords

ACETYLCHOLINESTERASE; ALKALOID; CHOLINESTERASE INHIBITOR; DEOXYVASICINE; DEOXYVASICINONE; HARMALINE; HARMAN; HARMINE; HARMOL; NIGELLASTRINE I; NIGELLASTRINE II; UNCLASSIFIED DRUG; VASICINE; VASICINONE;

ALZHEIMER DISEASE; ARTICLE; ASSAY; BIOASSAY; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CHINA; CHOLINESTERASE INHIBITION; DRUG ISOLATION; ENZYME INHIBITION; IN VITRO STUDY; NONHUMAN; PEGANUM HARMALA; PEGANUM NIGELLASTRUM BUNGE; PLANT SEED; PROTON NUCLEAR MAGNETIC RESONANCE; THIN LAYER CHROMATOGRAPHY;

ALKALOIDS; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, THIN LAYER; PEGANUM; SEEDS;

EID: 70349554496     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1910-x     Document Type: Article

References (27)

1. D. H. Aarons G. V. Rossi R. F. Orzechowski 1977 Cardiovascular actions of three harmala alkaloids: harmine, harmaline, and harmalol J. Pharm. Sci. 66 1244 1248 903860 10.1002/jps.2600660910 1:CAS:528:DyaE2sXlvFeqsbY%3D (Pubitemid 8163970)
2. A. Ahmad K. A. Khan S. Sultana B. S. Siddiqui S. Begum S. Faizi S. Siddiqui 1992 Study of the in vitro antimicrobial activity of harmine, harmaline and their derivatives J. Ethnopharmacol. 35 289 294 1548902 10.1016/0378-8741(92)90027-O 1:CAS:528:DyaK38XhvFSqs7w%3D
3. M. M. Airaksinen I. Kari 1981 β-carbolines, psychoactive compounds in the mammalian body. Part I: Occurrence, origin and metabolism Med. Biol. 59 1 21 34 7022042 1:CAS:528:DyaL3MXitVGqu7k%3D
4. R. Becker E. Giacobini R. Elble M. Mcllhany K. Sherman 1988 Potential pharmacotherapy of Alzheimer disease. A comparison of various forms of physostigmine administration Acta Neurol. Scand. Suppl. 116 19 32 3043998 10.1111/j.1600-0404.1988.tb07983.x 1:STN:280:DyaL1czgs1Omug%3D%3D
5. K. Blennow M. J. de Leon H. Zetterberg 2006 Alzheimer's disease Lancet 368 387 403 16876668 10.1016/S0140-6736(06)69113-7 1:CAS:528: DC%2BD28XnsFymsbY%3D (Pubitemid 44108123)
6. G. M. Bores F. P. Huger W. Petko A. E. Mutalib F. Camacho D. K. Rush D. E. Selk V. Wolf R. W. Kosley L. Davis H. M. Vargas 1996 Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine J. Pharmacol. Exp. Ther. 277 728 738 8627552 1:CAS:528:DyaK28XivFehsLk%3D
7. C. Di Giorgio F. Delmas E. Ollivier R. Elias G. Balansard P. Timon-David 2004 In vitro activity of the β-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum Exp. Parasitol. 106 67 74 15172213 10.1016/j.exppara.2004.04.002 (Pubitemid 38686275)
8. J. A. Duan C. T. Che R. H. Zhou S. X. Zhao M. S. Wang 1998 Studies on the chemical constituents of Peganum multisectum Maxim II. Flavonoids and alkaloids from aerial part of plant J. Chin. Pharm. Univ. 29 100 104 1:CAS:528: DyaK1cXjvFCqs7k%3D
9. J. A. Duan R. H. Zhou C. T. Che M. S. Wang S. X. Zhao 1998 Studies on the chemicaI constituents of Peganum multisectum Maxim I. The alkaloids from seeds and antitumour activity J. Chin. Pharm. Univ. 29 21 23 1:CAS:528: DyaK1cXjvFGjsro%3D
10. F. Forette R. Anand G. Gharabawi 1999 A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (ExXelon) Eur. J. Neurol. 6 423 429 10362894 10.1046/j.1468-1331.1999.640423.x 1:STN:280:DyaK1M3pt12rtw%3D%3D
11. P. T. Francis A. M. Palmer M. Snape G. K. Wilcock 1999 The cholinergic hypothesis of Alzheimer's disease: a review of progress J. Neurol. Neurosurg. Psychiatry. 66 137 147 10071091 10.1136/jnnp.66.2.137 1:STN:280: DyaK1M7mvVKnuw%3D%3D
12. B. Fulton P. Benfield 1996 Galanthamine Drugs Aging 9 60 65 8818586 10.2165/00002512-199609010-00006 1:CAS:528:DyaK28XmslajtLs%3D
13. R. A. Glennon M. Dukat B. Grella S. Hong L. Costantino M. Teitler C. Smith C. Egan K. Davis M. V. Mattson 2000 Binding of b-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors Drug Alcohol. Depend. 60 121 132 10940539 10.1016/S0376-8716(99)00148- 9 1:CAS:528:DC%2BD3cXlsFCis70%3D (Pubitemid 30625015)
14. S. M. Husbands R. A. Glennon S. Gorgerat R. Gough R. Tyacke J. Crosby D. J. Nutt J. W. Lewis A. L. Hudson 2001 β-carboline binding to imidazoline receptors Drug Alcohol. Depend. 64 203 208 11543990 10.1016/S0376-8716(01)00123- 5 1:CAS:528:DC%2BD3MXmsFemurk%3D (Pubitemid 32816963)
15. H. Kim S. O. Sablin R. R. Ramsay 1997 Inhibition of monoamine oxidase A by b-carboline derivatives Arch. Biochem. Biophys. 337 137 142 8990278 10.1006/abbi.1996.9771 1:CAS:528:DyaK2sXktlGitg%3D%3D (Pubitemid 27198065)
16. F. Lamchouri A. Settaf Y. Cherrah M. Hassar M. Zemzami N. Atif E. B. Nadori A. Zaid B. Lyoussi 2000 In vitro cell-toxicity of Peganum harmala alkaloids on cancerous cell-lines Fitoterapia 71 50 54 11449470 10.1016/S0367-326X(99)00117-3 1:CAS:528:DC%2BD3cXhvFertLk%3D (Pubitemid 30012017)
17. F. Lamchouri A. Settaf Y. Cherrah M. Zemzami B. Lyoussi A. Zaid N. Atif M. Hassar 1999 Antitumour principles from Peganum harmala Therapie. Paris. 54 753 758 10709452 1:STN:280:DC%2BD3c7nsVahug%3D%3D
18. J. Lutes J. F. Lorden M. Beales G. A. Oltmans 1988 Tolerance to the tremorogenic effects of harmaline: evidence for altered olivo-cerebellar function Neuropharmacol. 27 849 855 10.1016/0028-3908(88)90102-5 1:CAS:528:DyaL1cXlsVOgur8%3D (Pubitemid 18201449)
19. J. Ma X. L. Wang 1998 The species and distribution of genus Peganum in the desert area of China J. Desert Res. 18 131 136
20. J. Ma Y. J. Li 1996 A resistant plant to desert: Peganum harmala Plant Resources 1 3 4
21. A. Marston J. Kissling K. Hostettmann 2002 A Rapid TLC Bioautographic Method for the Detection of Acetylcholinesterase and Butyrylcholinesterase Inhibitors in Plants Phytochem. Anal. 13 51 54 11899607 10.1002/pca.623 1:CAS:528:DC%2BD38XhtV2ntLo%3D (Pubitemid 34126614)
22. W. Pfau K. Skog 2004 Exposure to b-carbolines norharman and harman J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 802 115 126 15036003 10.1016/j.jchromb.2003.10.044 1:CAS:528:DC%2BD2cXht1yjsLg%3D (Pubitemid 38224277)
23. Pharmacopoeia Commission, Ministry of Pubic Health, 1998. Standard of Uygur drug, Drug Standard of Ministry of Health of the people's republic of China, Technology & Public Health Press, Xinjiang, pp. 80 (1998)
24. M. J. Schwarz P. J. Houghton S. Rose P. Jenner A. D. Lees 2003 Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism Pharmacol. Biochem. Behav. 75 627 633 12895680 10.1016/S0091-3057(03)00129-1 1:CAS:528:DC%2BD3sXlvVWhsLk%3D (Pubitemid 36936896)
25. A. M. Sobhani S. A. Ebrahimi M. Hoormand N. Rahbar M. Mahmoudian 2002 Cytotoxicity of Peganum harmala L. seeds extract and its relationship with contents of β-carboline alkaloids J. Iran. Un.i Med. Sci. 8 432 438
26. C. H. Wang J. Liu L. M. Zheng Y. M. Lin X. G. Zou M. Chen D. J. Sun 2002 Analysis of harmine and harmaline of Peganum harmala in different parts and different localities Chin. Pharm. J. 37 211 215 1:CAS:528:DC%2BD38XjvVantrg%3D
27. P. J. Whitehouse D. L. Price R. G. Struble A. W. Clark J. T. Coyle M. R. DeLong 1982 Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain Science 215 1237 1239 7058341 10.1126/science.7058341 1:STN:280:DyaL387ivFWntQ%3D%3D